1. Xenogeneic-free culture of human intestinal stem cells on functional polymer-coated substrates for scalable, clinical-grade stem cell therapy.
- Author
-
Park S, Kwon O, Lee H, Cho Y, Yeun J, Yoon SH, Sun SY, Huh Y, Yu WD, Park S, Son N, Jeon S, Lee S, Kim DS, Lee SY, Son JG, Lee KJ, Kim YI, Lim JH, Yoo J, Lee TG, Son MY, and Im SG
- Subjects
- Humans, Animals, Mice, Stem Cells cytology, Stem Cell Transplantation methods, Intestines cytology, Intestinal Mucosa cytology, Laminin chemistry, Polymers chemistry, Pluripotent Stem Cells cytology, Cell Differentiation, Cells, Cultured, Collagen, Drug Combinations, Proteoglycans, Organoids cytology, Cell Culture Techniques methods
- Abstract
The need for basement membrane extract (BME) with undefined constituents, such as Matrigel, for intestinal stem cell (ISC) culture in traditional systems poses a significant barrier that must be overcome for the development of clinical-grade, scalable, ready-to-use ISCs. Here, we propose a functional polymer-based xenogeneic-free dish for the culture of intestinal stem cells (XF-DISC), ensuring substantially prolonged maintenance of ISCs derived from 3-dimensional human intestinal organoids (ISCs
3D-hIO ). XF-DISC enables remarkable expandability, exhibiting a 24-fold increase in cell numbers within 30 days, with long-term maintenance of ISCs3D-hIO for more than 30 consecutive passages (>210 days). In addition, XF-DISC is fully compatible with a cell banking system. Notably, human pluripotent stem cell-derived ISCs3D-hIO cultured on XF-DISC are successfully transplanted into intestinal injury and inflammation mouse models, leading to engraftment and regeneration of damaged mouse intestinal epithelium. As a reliable and scalable xenogeneic-free ISC3D-hIO culture method, XF-DISC is highly promising for the development of regenerative ISC therapy for human intestinal diseases., Competing Interests: Competing interests: The authors declare no competing interests. Ethical considerations of working with human cells and animals: This study complies with all relevant ethical regulations. All studies based on human pluripotent stem cells were approved by the Korean Public IRB (IRB number: P01-201409-ES-01-09, P01-201609-31-002). Male NIG mice (Nod/scid-IL2Rgem1/GH, 6–12 weeks old; GHBio, Daejeon, Korea) were housed in a specific pathogen-free facility with a controlled 12-hour light/dark cycle, temperature maintained at 20-22 °C, and relative humidity at 55 ± 5%. The mice were provided with ad libitum access to water and fed a purified AIN-76A diet (Teklad Custom Research Diet, CA.170481; Envigo, Indianapolis, IN, USA). All animal experiments were approved by the Institutional Animal Care and Use Committee (IACUC) of KRIBB (KRIBB-AEC-22233). For the study based on human blood, informed consent was obtained prior to participation with approval from the IRB at Yonsei University Health System (IRB No. 3-2023-0347)., (© 2024. The Author(s).)- Published
- 2024
- Full Text
- View/download PDF